THC binds CB1 receptors by fitting into a fatty pocket on the receptor, where it acts as a partial agonist. That fit changes the receptor's shape and sets off a cascade of G-protein signals inside the cell. The result is not a simple on-or-off switch; it is a graded response that shapes the intensity and character of cannabis effects.
what makes cb2 receptors an anti inflammatory target
The CB1 receptor and where THC docks
CB1 receptors are among the most abundant G-protein-coupled receptors in the brain. They sit in the membrane with a binding site that is deep, greasy, and lined with aromatic residues. THC, being fat-soluble, slides into that pocket rather than floating through the watery space outside the cell. Key interactions involve hydrogen bonding with a serine residue and hydrophobic contacts with phenylalanine and tryptophan residues. These contacts hold THC in place long enough to trigger a response.
cannabinoid receptor agonists and antagonists
- CB1 is a G-protein-coupled receptor (GPCR) with seven transmembrane segments.
- The binding pocket is lipophilic, which suits THC's oily chemical structure.
- THC forms specific bonds with residues such as serine 383 and phenylalanine 3.36.
What partial agonist means for THC
THC is a partial agonist at CB1. It activates the receptor, but less completely than full agonists like some synthetic cannabinoids. That partial activity helps explain why THC has a ceiling on its effects and why it can sometimes behave like an antagonist when a stronger agonist is present. The binding affinity of THC is in the low nanomolar range, which is potent but not extreme.
Do CBD and THC Act on Different Receptors?
Partial agonism also means THC can produce different effects across brain regions depending on how much receptor reserve is available. In areas with many spare receptors, THC may produce a strong signal. In areas with fewer receptors, the effect is muted.
The signaling cascade after binding
Once THC binds, the CB1 receptor changes shape and activates Gi/o proteins. This leads to:
- Inhibition of adenylyl cyclase, reducing cyclic AMP.
- Activation of potassium channels, which makes neurons less likely to fire.
- Inhibition of voltage-gated calcium channels, reducing neurotransmitter release.
- Activation of mitogen-activated protein kinase pathways, which can affect gene expression.
These signals combine to alter mood, memory, appetite, and pain perception. The effects depend on where in the brain the CB1 receptors are located and how much THC reaches them.
Why binding location and convenience matter
THC's effects depend on how fast it reaches CB1 receptors. Inhaled THC hits the bloodstream quickly, producing a near-immediate peak at receptors. Edibles must pass through the digestive system, and the liver converts THC into 11-hydroxy-THC, which is also active at CB1. That delayed route can lead to a slower onset but longer duration.
Convenience products such as vapes, beverages, and pre-dosed edibles change the timing and dose of THC delivery. A fast, convenient format can make it easier to overshoot a comfortable dose because the feedback loop between feeling effects and taking more is compressed. Slower formats allow more time for the drug to bind and for the user to adjust. Understanding how THC binds CB1 receptors does not require a lab coat, but it does explain why the delivery method shapes the experience as much as the dose.